Valeant Pharmaceuticals Proposes to Acquire ISTA Pharmaceuticals Inc. for $6.50 Per Share in Cash. The proposed transaction has a total equity value of approximately $314 million on a fully diluted basis. In addition, ISTA has net debt of approximately $13 million, bringing the total enterprise value to approximately $327 million.
Check out news at
www.prnewswire.com/news-releases/valeant-pharmaceuticals-proposes-to-acquire-ista-pharmaceuticals-inc-for-650-per-share-in-cash-135724338.html
No comments:
Post a Comment